Myofibroblasts are a unique class of cells critical in normal human organogenesis and wound repair. Dysregulation of the normal mechanisms of myofibroblast apoptosis are proposed to play a role in the development of fibroproliferative diseases such as idiopathic pulmonary fibrosis. Therefore the goals of this proposal are to (i) identify the mechanisms that allow myofibroblasts to be eliminated at the completion of normal wound repair and (ii) uncover the mechanisms by which a specific survival pathway involving Akt/protein kinase B protects myofibroblasts from apoptosis. Based upon data from our laboratory and others, we hypothesize that (i) death receptor activation with its resultant caspase-8 and effector caspase activation is necessary for growth factor withdrawal-induced apoptosis and that (ii) the p53 tumor suppressor gene modulates the apoptotic signal through its effects on death receptor expression and trafficking, death ligand expression and the Bcl-2 family of proteins. In addition, we propose that (iii) Akt mediates its pro- survival effects through as-of-yet unidentified mechanisms, potentially including: (i) death receptor phosphorylation, (ii) death receptor localization, (iii) FADD phosphorylation and (iv) inhibition of p53- dependent transcription. These hypotheses will be tested in a growth factor withdrawal model of apoptosis in the CCL39 myofibreblast cell line and in primary cultured myofibroblasts of murine origin. Ultimately, the techniques, strategies and results of these studies can be applied to a range of fibroproliferative diseases and serve as a basis for developing novel pharmacologic targets for new therapies for fibrotic lung disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08HL067848-05
Application #
7156205
Study Section
Special Emphasis Panel (ZHL1-CSR-M (O1))
Program Officer
Colombini-Hatch, Sandra
Project Start
2003-01-01
Project End
2007-12-31
Budget Start
2007-01-01
Budget End
2007-12-31
Support Year
5
Fiscal Year
2007
Total Cost
$123,147
Indirect Cost
Name
National Jewish Health
Department
Type
DUNS #
076443019
City
Denver
State
CO
Country
United States
Zip Code
80206
Van Linden, Annemie A; Cottin, Vincent; Frankel, Stephen K et al. (2005) Hierarchical phosphorylation of the TNF-alpha receptor, TNF-R1, by p42Mapk/Erk at basic Pro-directed kinase sites. Biochemistry 44:6980-9
Frankel, Stephen K; Moats-Staats, Billie M; Cool, Carlyne D et al. (2005) Human insulin-like growth factor-IA expression in transgenic mice promotes adenomatous hyperplasia but not pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 288:L805-12
Wynes, Murry W; Frankel, Stephen K; Riches, David W H (2004) IL-4-induced macrophage-derived IGF-I protects myofibroblasts from apoptosis following growth factor withdrawal. J Leukoc Biol 76:1019-27